Piper Sandler Reiterates Overweight on CVRx, Raises Price Target to $16
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Matt O'Brien has reiterated an Overweight rating on CVRx and increased the price target from $13 to $16.
October 30, 2024 | 4:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler has reiterated an Overweight rating on CVRx and increased the price target from $13 to $16, indicating a positive outlook.
The reiteration of an Overweight rating and an increased price target from a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100